Bharat Biotech IPO coming up

Vaccine maker Bharat Biotech is preparing to sell its shares. No further details are known. Bloomberg reports that the approximate amount of the deal is to raise $500 million, citing reliable sources.

Bharat Biotech, which started operations in 1996, has already made great strides in vaccine manufacturing. The product line includes the Covid vaccine Covaxin, hepatitis B, and diarrhea prevention drugs. Dr. Krishna Ella and his wife Dr. Suchitra Ella are the founding promoters of Hyderabad-based Bharat Biotech. This is also the company that discovered the first vaccines for viral diseases like Chikungunya and Zika. They also have the H1N1 vaccine. 145 global patents, 19 vaccines. There are many favorable factors for Bharat Biotech IPO to be successful. What will be the issue price? How much is the premium? The investor response will be accordingly.